Unravelling the Role of Serum Kallistatin on Cardiorenal Outcomes in Kidney Transplant Survivors
Introduction: Kallistatin, a serine protease inhibitor, has been implicated in cardiovascular and renal protection. This study investigates its association with clinical characteristics and outcomes in long-term kidney transplant recipients (KTRs). Methods: In this longitudinal observatio...
Saved in:
| Main Authors: | Krzysztof Batko, Anna Sączek, Małgorzata Banaszkiewicz, Jolanta Małyszko, Ewa Koc-Żórawska, Marcin Żórawski, Karolina Niezabitowska, Katarzyna Siek, Andrzej Kraśniak, Marcin Krzanowski, Katarzyna Krzanowska |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Karger Publishers
2025-01-01
|
| Series: | Kidney & Blood Pressure Research |
| Online Access: | https://karger.com/article/doi/10.1159/000543652 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Risk prediction of kidney function in long-term kidney transplant recipients
by: Krzysztof Batko, et al.
Published: (2025-03-01) -
Quantitative ELISA for SERPINA4/kallistatin
by: Kurpad Nagaraj Shashidhar, et al.
Published: (2021-11-01) -
Evaluation of Kallistatin Levels in COPD Exacerbations
by: Kadir Burak Akgün, et al.
Published: (2025-01-01) -
Mid-term and late results of endovascular treatment for symptomatic carotid artery stenosis under proximal protection
by: Paweł Latacz, et al.
Published: (2020-04-01) -
Role of kallistatin in pediatric patients with pulmonary arterial hypertension
by: Özge Pamukçu, et al.
Published: (2020-06-01)